Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma

Annemiek Broijl, Marie-Jose Kersten, Wendimagegn Ghidey Alemayehu, Mark-David Levin, Okke de Weerdt, Edo Vellenga, Ellen Meijer, Shulamit Wittebol, Bea C. Tanis, Petra B. Cornelisse, Marian Stevens-Kroef, Gerard M. J. Bos, Pierre W. Wijermans, Henk Lokhorst, Pieter Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalHaematologica
Volume101
Issue number4
DOIs
Publication statusPublished - Apr 2016

Cite this

Broijl, A., Kersten, M-J., Alemayehu, W. G., Levin, M-D., de Weerdt, O., Vellenga, E., ... Sonneveld, P. (2016). Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma. Haematologica, 101(4). https://doi.org/10.3324/haematol.2015.132431